Drug recall · August 8, 2012
Dorzolamide HCI/Timolol Maleate Ophthalmic Solution 22.3mg/6.8mg per mL recall
Why: Presence of Particulate Matter: Lots identified in this recall notification may contain small particulates.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dorzolamide HCI/Timolol Maleate Ophthalmic Solution 22.3mg/6.8mg per mL, 10mL bottle, For Topical Application in the Eye, Sterile Ophthalmic Solution, Rx Only, Mfg by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9
- Lots / codes
Lot #s: JN1060, JN1061, JN1062, Exp 06/12
- Quantity
- 119,794 Bottles
- Company
- Apotex Inc., Toronto, N/A
- Distribution
- Nationwide and Puerto Rico
- Initiated
- April 30, 2012 · Voluntary: Firm initiated
- Classified
- August 2, 2012
- Reported
- August 8, 2012
- Ended
- September 19, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Timolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.